TP53 and colorectal carcinoma: Notably, p53MT did not exhibit age‐dependent reduction despite its CRC grade‐dependent reduction due to the range of the used antibody, which detecting not only the R273H p53 variant but also others unrelated to the transactivation region of p53 (Figure 2e,f).